Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease

被引：3
|
作者：
Lee, Yong-ho [1 ,2 ]
Kim, Seung Up [1 ,3 ,4 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Yonsei Ro 50, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Inst Endocrine Res, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea
[4] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
HEPATOLOGY INTERNATIONAL | 2020年 / 14卷 / 01期
基金：
新加坡国家研究基金会;
关键词：
OBESITY; MUSCLE;
D O I：
10.1007/s12072-019-09999-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：5 / 7
页数：3
相关论文
共 50 条
  • [1] Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease
    Yong-ho Lee
    Seung Up Kim
    [J]. Hepatology International, 2020, 14 : 5 - 7
  • [2] Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
    Riccardo M. Inciardi
    Alessandro Mantovani
    Giovanni Targher
    [J]. Current Heart Failure Reports, 2023, 20 : 308 - 319
  • [3] Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
    Inciardi, Riccardo M.
    Mantovani, Alessandro
    Targher, Giovanni
    [J]. CURRENT HEART FAILURE REPORTS, 2023, 20 (04) : 308 - 319
  • [4] Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
    Iwaki, Michihiro
    Kobayashi, Takashi
    Nogami, Asako
    Saito, Satoru
    Nakajima, Atsushi
    Yoneda, Masato
    [J]. NUTRIENTS, 2023, 15 (04)
  • [5] SARCOPENIA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Yerragorla, Priyanka
    Nepal, Pankaj
    Nekkalapudi, Divya
    Andreias, Laura
    Ahmed, Shady
    Dabas, Ritu
    Mousavi, Ali
    Morcos, Morcos
    Matari, Hussein
    Harley, Jennifer
    Bergasa, Nora V.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1174 - S1175
  • [6] Sarcopenia and Risk of Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
    Wijarnpreecha, Karn
    Panjawatanan, Panadeekarn
    Thongprayoon, Charat
    Jaruvongvanich, Veeravich
    Ungprasert, Patompong
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S507 - S508
  • [7] Sarcopenia is a new risk factor of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Jang, B. I.
    Kim, K. O.
    Yang, C. H.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S507 - S507
  • [8] The association between sarcopenia and non-alcoholic fatty liver disease
    Hu, Yi-Bing
    Chen, Ze
    Fu, Rong-Quan
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : 243 - 244
  • [9] Management of non-alcoholic fatty liver disease in patients with sarcopenia
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (02) : 221 - 233
  • [10] Emerging drugs for non-alcoholic fatty liver disease
    Federico, Alessandro
    Niosi, Marco
    Blanco, Camillo Del Vecchio
    Loguercio, Carmela
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) : 145 - 158
12345